These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24250666)

  • 1. Preparation and in-vitro Evaluation of an Antisense-containing Cationic Liposome against Non-small Cell Lung Cancer: a Comparative Preparation Study.
    Saffari M; H Shirazi F; Oghabian MA; Moghimi HR
    Iran J Pharm Res; 2013; 12(Suppl):3-10. PubMed ID: 24250666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terpene-loaded Liposomes and Isopropyl Myristate as Chemical Permeation Enhancers Toward Liposomal Gene Delivery in Lung Cancer cells; A Comparative Study.
    Saffari M; Hoseini Shirazi F; Moghimi HR
    Iran J Pharm Res; 2016; 15(3):261-267. PubMed ID: 27980561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes loaded with betel leaf (Piper betle L.) ethanolic extract prepared by thin film hydration and ethanol injection methods: Characteristics and antioxidant activities.
    Tagrida M; Prodpran T; Zhang B; Aluko RE; Benjakul S
    J Food Biochem; 2021 Dec; 45(12):e14012. PubMed ID: 34800041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
    Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
    Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and in vitro and in vivo study of antisense oligodeoxynucleotides-loaded cationic liposomes].
    Liu Y; Zhang ZZ; Li K; Mei Q
    Yao Xue Xue Bao; 2009 Nov; 44(11):1273-7. PubMed ID: 21355327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of cholesterol modified cationic lipids for liposomal drug delivery of antisense oligonucleotides.
    Zimmer A; Aziz SA; Gilbert M; Werner D; Noe CR
    Eur J Pharm Biopharm; 1999 Mar; 47(2):175-8. PubMed ID: 10234543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on preparative methods of DC-Chol/DOPE liposomes and formulation optimization by determining encapsulation efficiency.
    Yang S; Chen J; Zhao D; Han D; Chen X
    Int J Pharm; 2012 Sep; 434(1-2):155-60. PubMed ID: 22643228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.
    Stuart DD; Kao GY; Allen TM
    Cancer Gene Ther; 2000 Mar; 7(3):466-75. PubMed ID: 10766353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems.
    Elsana H; Olusanya TOB; Carr-Wilkinson J; Darby S; Faheem A; Elkordy AA
    Sci Rep; 2019 Oct; 9(1):15120. PubMed ID: 31641141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability.
    Stuart DD; Allen TM
    Biochim Biophys Acta; 2000 Feb; 1463(2):219-29. PubMed ID: 10675501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.
    Mansourian M; Badiee A; Jalali SA; Shariat S; Yazdani M; Amin M; Jaafari MR
    Immunol Lett; 2014 Nov; 162(1 Pt A):87-93. PubMed ID: 25086399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
    Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
    J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells.
    Valizadeh H; Ghanbarzadeh S; Zakeri-Milani P
    Drug Dev Ind Pharm; 2015; 41(9):1558-65. PubMed ID: 25311425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
    Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
    Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
    J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
    Rait AS; Pirollo KF; Xiang L; Ulick D; Chang EH
    Mol Med; 2002 Aug; 8(8):475-86. PubMed ID: 12435858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
    Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
    Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on the preparation process of the cytarabine/daunorubicin dual-encapsulation liposome and its physicochemical properties and performances in vitro/vivo.
    Liu B; Zhang J; Liu Z; Wang P; Zhang Y; He H; Yin T; Gou J; Tang X
    Int J Pharm; 2023 Nov; 646():123500. PubMed ID: 37820944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.